Skip to main content
SpringerLink
Log in

Role of microRNA in Normal and Malignant Hematopoiesis

  • Chapter
  • First Online:
Hematopathology

  • 1295 Accesses

Abstract

Epigenetic modifications in the recent era have received a lot of attention in a variety of diseases particularly cancer. They are defined as the modulation of gene expression by chromatin modification that does not involve DNA sequence alterations [1]. These modifications act either by altering the chromatin structure to deregulate gene expression or by the post-translational modification. Consequently, epigenetics control cell differentiation and function by “switching on” or “off” certain gene expressions, and a disruption of the normal epigenetic mechanism can lead to uncontrolled gene activation or silencing resulting into an altered homeostasis. Three main types of epigenetic processes which have been identified include DNA methylation, nucleosomal histone modifications, and post-translational alterations by the non-coding RNAs [2]. Prominent among these non-coding RNAs are microRNAs (miRNAs), which have recently emerged as important players in the regulation of normal hematopoietic cell development and differentiation as well as in malignant transformation. In this chapter, we have provided a comprehensive summary of the current knowledge on the role of miRNAs in normal and aberrant hematopoiesis with a focus on the clinical significance of the deranged miRNAs in some of the common hematological neoplasms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weinhold B. Epigenetics: the science of change. Environ Health Perspect. 2006;114(3):A160–7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Rice KL, Hormaeche I, Licht JD. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene. 2007;26(47):6697–714.

    Article  CAS  PubMed  Google Scholar 

  3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.

    Article  CAS  PubMed  Google Scholar 

  4. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics. 2014;2014:970607.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(Database issue):D140–4.

    Article  CAS  PubMed  Google Scholar 

  7. Vasudevan S. Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Rev RNA. 2012;3(3):311–30.

    Article  CAS  PubMed  Google Scholar 

  8. Hong SH, Kim KS, Oh IH. Concise review: exploring miRNAs—toward a better understanding of hematopoiesis. Stem Cells. 2015;33(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  9. Guo S, Lu J, Schlanger R, Zhang H, Wang JY, Fox MC, et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci U S A. 2010;107:14229–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, et al. Dicer is essential for mouse development. Nat Genet. 2003;35(3):215–7.

    Article  CAS  PubMed  Google Scholar 

  11. Kotaki R, Koyama-Nasu R, Yamakawa N, Kotani A. miRNAs in normal and malignant hematopoiesis. Int J Mol Sci. 2017;18(7):1495.

    Article  PubMed Central  Google Scholar 

  12. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small library sequencing. Cell. 2007;129:1401–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Petriv OI, Kuchenbauer F, Delaney AD, Lecault V, White A, Kent D, et al. Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A. 2010;107(35):15443–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Georgantas RW III, Hildreth R, Morisot S, Alder J, Liu C-g, Heimfeld S, et al. CD34+ hematopoietic stem progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007;104(8):2750–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bissels U, Wild S, Tomiuk S, Hafner M, Scheel H, Mihailovic A, et al. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Stem Cells. 2011;29:847–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bhagavathi S, Czader M. MicroRNAs in benign and malignant hematopoiesis. Arch Pathol Lab Med. 2010;134:1276–81.

    CAS  PubMed  Google Scholar 

  17. Pelosi E, et al. MicroRNAs in normal and malignant myelopoiesis. Leuk Res. 2009;33:1584–93.

    Article  CAS  PubMed  Google Scholar 

  18. Mukai HY, Motohashi H, Ohmeda O, Suzuki N, Nagano M, Yamamoto M. Transgene insertion in proximity to thr c-myb gene disrupts erythroid megakaryocytic lineage bifurcation. Mol Cell Biol. 2006;26:7953–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. The regulated expression of miRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol. 2007;35(11):1657–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lisio LD, Martinez N, Montes-Moreno S, Piris-Villaespesa M, Sanchez-Beato M, Piris MA. The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. Blood. 2012;120(9):1782–90.

    Article  PubMed  Google Scholar 

  21. Johanson TM, Skinner JPJ, Kumar A, et al. The role of microRNAs in lymphopoiesis. Int J Hematol. 2014;100:246.

    Article  CAS  PubMed  Google Scholar 

  22. Zhang J, Jima DD, Jacobs C, et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood. 2009;113(19):4586–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood. 2011;117:7053–62.

    Article  CAS  PubMed  Google Scholar 

  24. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147–61.

    Article  CAS  PubMed  Google Scholar 

  25. Lagana A, Russo F, Sismeiro C, Giugno R, Pulvirenti A, Ferro A. Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material. PLoS One. 2010;5(6):e11166.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zenz T, Mohr J, Eldering E, et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood. 2009;113:3801–8.

    Article  CAS  PubMed  Google Scholar 

  28. Deshpande A, Pastore A, Deshpande AJ, Zimmermann Y, Hutter G, Weinkauf M, et al. 3’UTR mediated regulation of the cyclin D1 protooncogene. Cell Cycle. 2009;8(21):3592–600.

    Article  CAS  PubMed  Google Scholar 

  29. Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, et al. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica. 2012;97(4):586–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, et al. Microrna expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007;121:1156–61.

    Article  CAS  PubMed  Google Scholar 

  31. Ni H, Tong R, Zou L, Song G, Cho WC. MicroRNAs in diffuse large B-cell lymphoma. Oncol Lett. 2016;11(2):1271–80.

    Article  CAS  PubMed  Google Scholar 

  32. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A. 2008;105(35):12885–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Seckinger A, Meißner T, Moreaux J, Benes V, Hillengass J, Castoldi M, et al. miRNAs in multiple myeloma—a survival relevant complex regulator of gene expression. Oncotarget. 2015;6(36):39165–83.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Rossi M, Tagliaferri P, Tassone P. MicroRNAs in multiple myeloma and related bone disease. Ann Transl Med. 2015;3(21):334.

    PubMed  PubMed Central  Google Scholar 

  35. Starczynowski DT, Morin R, McPherson A, Lam J, Chari R, Wegrzyn J, et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood. 2011;117(2):595–607.

    Article  CAS  PubMed  Google Scholar 

  36. Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, et al. Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br J Haematol. 2011;153(1):24–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Pons A, Nomdedeu B, Navarro A, Gaya A, Gel B, Diaz T, et al. Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma. 2009;50:1854–9.

    Article  CAS  PubMed  Google Scholar 

  38. Hussein K, Theophile K, Büsche G, Schlegelberger B, Göhring G, Kreipe H, et al. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells. Leuk Res. 2010;34(9):1169–74.

    Article  CAS  PubMed  Google Scholar 

  39. Song SJ, Pandolfi PP. MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia. Curr Opin Hematol. 2014;21(4):276–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Scholl S, Fricke HJ, Sayer HG, Hoffken K. Clinical implications of molecular genetic aberrations in acute myeloid leukemia. J Cancer Res Clin Oncol. 2009;135:491–505.

    Article  PubMed  Google Scholar 

  41. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008;111(6):3183–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Wang Y, Li Z, He C, Wang D, Yuan X, Chen J, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis. 2010;44(3):191–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. de Oliveira JC, Scrideli CA, Brassesco MS, Morales AG, Pezuk JA, Queiroz Rde P, et al. Differential miRNA expression in childhood ALL and association with clinical and biological features. Leuk Res. 2012;36(3):293–8.

    Article  PubMed  Google Scholar 

  44. Schotte D, De Menezes RX, Akbari Moqadam F, Khankahdani LM, Lange-Turenhout E, Chen C, et al. MicroRNA characterizes genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica. 2011;96(5):703–11.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Sanghvi VR, Mavrakis KJ, Van der Meulen J, Boice M, Wolfe AL, Carty M, et al. Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia. Sci Signal. 2014;7(352):ra111.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Saki N, Abroun S, Soleimani M, Hajizamani S, Shahjahani M, Kast RE, et al. Involvement of microRNA in T-cell differentiation and malignancy. Int J Hematol Oncol Stem Cell Res. 2015;9(1):33–49.

    PubMed  PubMed Central  Google Scholar 

  47. Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU, et al. Expression of the miR-17- 92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood. 2007;109(10):4399–405.

    Article  CAS  PubMed  Google Scholar 

  48. San José-Enériz E, Román-Gómez J, Jiménez-Velasco A, Garate L, Martin V, Cordeu L, et al. MicroRNA expression profiling in imatinib-resistant chronic myeloid leukemia patients without clinically significant ABL1-mutations. Mol Cancer. 2009;8(1):69.

    Article  PubMed  PubMed Central  Google Scholar 

  49. de Planell-Saguer M, Rodicio MC. Detection methods for microRNAs in clinic practice. Clin Biochem. 2013;46(10–11):869–78.

    Article  PubMed  Google Scholar 

  50. Baker M. MicroRNA profiling: separating signal from noise. Nat Methods. 2010;7(9):687–92.

    Article  CAS  PubMed  Google Scholar 

  51. Ciccone M, Calin GA. MicroRNAs in myeloid hematological malignancies. Curr Genomics. 2015;16(5):336–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Ruchi Gupta & Khaliqur Rahman

Authors
  1. Ruchi Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khaliqur Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Hematology, All India Institute of Medical Sciences, New Delhi, India

    Renu Saxena

  2. Department of Hematology, All India Institute of Medical Sciences, New Delhi, India

    Hara Prasad Pati

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gupta, R., Rahman, K. (2019). Role of microRNA in Normal and Malignant Hematopoiesis. In: Saxena, R., Pati, H. (eds) Hematopathology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7713-6_26

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7713-6_26

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7712-9

  • Online ISBN: 978-981-13-7713-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation